DIA
BPMC

Dana Investment Advisors’s Blueprint Medicines BPMC Stock Holding History

Dana Investment Advisors’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-16,031
Closed -$2.05M – 562
2025
Q2 		$2.05M Sell
16,031
-21,520
-57% -$2.24M 0.07% 277
2025
Q1 		$3.32M Sell
37,551
-1,523
-4% -$149K 0.12% 207
2024
Q4 		$3.41M Buy
39,074
+2,282
+6% +$209K 0.11% 216
2024
Q3 		$3.4M Buy
36,792
+22,048
+150% +$2.19M 0.11% 216
2024
Q2 		$1.59M Buy
14,744
+1,114
+8% +$112K 0.05% 323
2024
Q1 		$1.29M Buy
13,630
+1,093
+9% +$93.7K 0.04% 348
2023
Q4 		$1.16M Sell
12,537
-5,273
-30% -$342K 0.06% 236
2023
Q3 		$894K Sell
17,810
-1,884
-10% -$101K 0.05% 246
2023
Q2 		$1.24M Sell
19,694
-637
-3% -$34.6K 0.06% 221
2023
Q1 		$915K Sell
20,331
-1,159
-5% -$52.2K 0.05% 247
2022
Q4 		$941K Buy
21,490
+8,846
+70% +$424K 0.05% 235
2022
Q3 		$833K Sell
12,644
-41
-0.3% -$2.63K 0.05% 239
2022
Q2 		$641K Buy
12,685
+309
+2% +$18.1K 0.03% 282
2022
Q1 		$791K Buy
12,376
+85
+0.7% +$6.1K 0.04% 237
2021
Q4 		$1.32M Sell
12,291
-6,976
-36% -$730K 0.06% 198
2021
Q3 		$1.98M Sell
19,267
-2,601
-12% -$242K 0.09% 133
2021
Q2 		$1.92M Buy
21,868
+3,292
+18% +$302K 0.09% 138
2021
Q1 		$1.81M Buy
18,576
+3,630
+24% +$362K 0.08% 153
2020
Q4 		$1.68M Sell
14,946
-3,699
-20% -$390K 0.08% 162
2020
Q3 		$1.73M Sell
18,645
-1,047
-5% -$80.6K 0.09% 123
2020
Q2 		$1.54M Buy
+19,692
New +$1.33M 0.08% 147

Other funds holding BPMC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Dana Investment Advisors's BPMC Position: Q3 2025 in Review

Dana Investment Advisors sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 16,031 shares — an estimated $2.05M sold.

Dana Investment Advisors first reported a position in BPMC in Q2 2020 and held it in 21 quarters. The position peaked at $3.41M in Q4 2024. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

  • Dana Investment Advisors reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
  • Dana Investment Advisors sold 16,031 Blueprint Medicines shares in Q3 2025, an estimated $2.05M.
  • Dana Investment Advisors first reported a position in Blueprint Medicines in Q2 2020 and held it in 21 quarters.
  • Dana Investment Advisors's Blueprint Medicines position peaked at $3.41M in Q4 2024.
  • 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on Dana Investment Advisors's 13F filing for Q3 2025, filed 10 Nov 2025.